Gufic Biosciences (BOM:509079) Institutional Ownership: 3.10% (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:509079 Gufic Biosciences Ltd BOM:509079
72 GF Score
Price ₹414.30
GF Value ₹348.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Gufic Biosciences Institutional Ownership?

Gufic Biosciences BOM:509079 -1.93% 72 Institutional Ownership is 3.10% as of Aug. 21, 2026. GuruFocus rates BOM:509079 with a GF Score™ of 72/100 and a GF Value™ of ₹348.74 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Gufic Biosciences's institutional ownership is 3.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Gufic Biosciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Gufic Biosciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Gufic Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Gufic Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences Institutional Ownership Chart

Gufic Biosciences Historical Data

The historical data trend for Gufic Biosciences can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 3.60 3.63 3.64 3.66 3.71 3.74 3.67 3.67 3.29 3.10
BOM:509079
72GF Score
Gufic Biosciences Ltd BOM:509079
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gufic Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.10% mean?
Gufic Biosciences (BOM:509079) has a Institutional Ownership of 3.10% as of Aug. 21, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Gufic Biosciences and its competitors.
Is Gufic Biosciences' Institutional Ownership too high?
Gufic Biosciences' current Institutional Ownership is 3.10%. Overall, Gufic Biosciences has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gufic Biosciences' Institutional Ownership compare to ZTS?
Gufic Biosciences' Institutional Ownership of 3.10% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Gufic Biosciences and its competitors. Gufic Biosciences's current Institutional Ownership is 3.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gufic Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Gufic Biosciences (BOM:509079) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹348.74, compared to a current price of ₹414.30 — trading 18.8% above its estimated fair value. The current Institutional Ownership is 3.10%. Gufic Biosciences' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Gufic Biosciences (BOM:509079), the current Institutional Ownership is 3.10% as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gufic Biosciences (BOM:509079) Overvalued in 2026?

Based on GuruFocus' analysis, Gufic Biosciences stock appears to be overvalued. The current stock price of ₹414.30 is trading 18.8% above its estimated GF Value™ of ₹348.74. GuruFocus considers Gufic Biosciences to be Modestly Overvalued.

Key valuation signals for BOM:509079:

  • Institutional Ownership: 3.10%
  • GF Value™: ₹348.74 vs. price of ₹414.30 (18.8% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the BOM:509079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gufic Biosciences Business Description

Other Exchanges GUFICBIO:India
Address SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.
72GF Score

Get the complete analysis for BOM:509079

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.30
Price
₹348.74
GF Value